In May and June 2018, the medicinal preparation Lozartan Plus JLLC Lekpharm was awarded contracts for the purchase of the Republic of Belarus for all three dosages in the international non-proprietary name Losartan + Hydrochlorothiazide.
Losartan Plus is the only domestic fixed combination of losartan and hydrochlorothiazide.
The novelty is available in three dosages of 50 mg / 12.5 mg, 100 mg / 12.5 mg, 100 mg / 25 mg, as tablets coated, 30 tablets per package.
The combination of two drugs (angiotensin II receptor blocker + diuretic hydrochlorothiazide) with different mechanisms of action in one Lozartan Plus tablet and convenient administration once a day makes it possible to greatly simplify the treatment of those patients with hypertension who need combination therapy.
Information on the award of the contract can be found at https://pharma.by/partners/information/